The merger of Strive and Semler Scientific consolidates their holdings into a $1.2 billion Bitcoin treasury, holding 10,900 BTC. The new entity now ranks among the top tier of corporate Bitcoin holders while weighing what to do with Semler’s profitable…The merger of Strive and Semler Scientific consolidates their holdings into a $1.2 billion Bitcoin treasury, holding 10,900 BTC. The new entity now ranks among the top tier of corporate Bitcoin holders while weighing what to do with Semler’s profitable…

Strive-Semler merger creates $1.2b Bitcoin treasury powerhouse

The merger of Strive and Semler Scientific consolidates their holdings into a $1.2 billion Bitcoin treasury, holding 10,900 BTC. The new entity now ranks among the top tier of corporate Bitcoin holders while weighing what to do with Semler’s profitable healthcare diagnostics arm.

Summary
  • Strive said it will merge with Semler Scientific in an all-stock deal at a 210% premium.
  • The combined entity creates a $1.2 billion Bitcoin treasury holding 10,900 BTC, ranking among top corporate holders.
  • Strive also purchased 5,816 BTC for $675 million ahead of the merger.

According to an announcement on September 22, Strive will absorb Semler Scientific in an all-stock transaction valued at a 210% premium. Crucially, Strive also revealed a concurrent purchase of 5,816 Bitcoin (BTC) for $675 million, a strategic move that immediately bolstered its balance sheet before the merger.

The combined entity will hold over 10,900 BTC, creating a colossal treasury that eclipses most other public companies. In a notable twist, the new leadership signaled a potential exit from the very medical diagnostics business that historically funded Semler’s own Bitcoin acquisitions.

Why Strive and Semler are joining forces

The companies framed the merger as a way to combine balance-sheet scale with operational optionality. Strive will maintain control of the new entity’s management team and board, while Semler Scientific’s executive chairman, Eric Semler, will take a board seat.

Per the release, the merger creates a corporate structure that can manage Bitcoin accumulation while deciding the fate of a profitable healthcare arm, with Strive planning to monetize or distribute Semler’s diagnostics business, or reposition it toward preventative care under new leadership.

The merger brings together two pioneers in the corporate Bitcoin space. Strive is identified as the first publicly traded asset management Bitcoin treasury company, with a mandate to outperform Bitcoin itself. Semler Scientific gained attention as the second U.S. public company to adopt Bitcoin as a primary treasury asset, using cash flows from its established medical diagnostics business to fund its purchases.

If completed, the deal would place the combined entity’s Bitcoin holdings at 10,900 BTC, positioning it as the twelfth-largest corporate holder of the original cryptocurrency, according to BitcoinTreasuries.net. That puts it just behind Tesla’s 11,509 BTC but far below Michael Saylor’s Strategy, which dominates the landscape with 639,835 BTC.

Piyasa Fırsatı
1 Logosu
1 Fiyatı(1)
$0.014828
$0.014828$0.014828
+19.60%
USD
1 (1) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Crypto.com Partner For Shareholder Token Airdrop

Trump Media & Technology Group (NASDAQ:DJT) has announced plans to distribute a new digital token to its shareholders, leveraging Crypto.com‘s infraread more
Paylaş
Coinstats2026/01/01 00:23
Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

Tria’s $20m beta surge: How a self-custodial neobank is redefining onchain finance

CEO Vijit Katta shares with crypto.news how Tria is reshaping digital asset banking and paving the way for a frictionless, user-controlled financial future.
Paylaş
Crypto.news2026/01/01 01:00
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Paylaş
BitcoinEthereumNews2025/09/18 06:29